142 related articles for article (PubMed ID: 2122090)
1. Tyrosinaemia type I with normal levels of plasma tyrosine.
de Almeida IT; Leandro PP; Silva MF; Silveira C; da Silva A; de Sousa JS; Duran M
J Inherit Metab Dis; 1990; 13(3):305-7. PubMed ID: 2122090
[No Abstract] [Full Text] [Related]
2. Type I hereditary tyrosinaemia: presentation of 11 cases.
Coşkun T; Ozalp I; Koçak N; Yüce A; Caglar M; Berger R
J Inherit Metab Dis; 1991; 14(5):765-70. PubMed ID: 1664010
[TBL] [Abstract][Full Text] [Related]
3. Liver transplantation in nine Spanish patients with tyrosinaemia type I.
Pérez-Cerdá C; Merinero B; Sanz P; Castro M; Gangoiti J; García MJ; Díaz M; Medina E; Ugarte M
J Inherit Metab Dis; 1995; 18(2):119-22. PubMed ID: 7564224
[No Abstract] [Full Text] [Related]
4. Dietary treatment eliminates succinylacetone from the urine of a patient with tyrosinaemia type 1.
Bain MD; Purkiss P; Jones M; Bingham P; Stacey TE; Chalmers RA
Eur J Pediatr; 1990 Jun; 149(9):637-9. PubMed ID: 2373116
[TBL] [Abstract][Full Text] [Related]
5. Hereditary tyrosinaemia.
Lancet; 1990 Jun; 335(8704):1500-1. PubMed ID: 1972437
[No Abstract] [Full Text] [Related]
6. The enzyme defects in hereditary tyrosinaemia type I.
Furukawa N; Hayano T; Sato N; Inoue F; Machida Y; Kinugasa A; Imashuku S; Kusunoki T; Takamatisu T
J Inherit Metab Dis; 1984; 7 Suppl 2():137-8. PubMed ID: 6434869
[No Abstract] [Full Text] [Related]
7. Plasma amino acid disturbance in infancy. I: Hypermethioninaemia and transient tyrosinaemia.
Komrower GM; Robins AJ
Arch Dis Child; 1969 Jun; 44(235):418-21. PubMed ID: 5785193
[No Abstract] [Full Text] [Related]
8. Methionine induction of experimental tyrosinaemia.
Perry TL; Hardwick DF; Hansen S; Pohlmann L; Warrington PD
J Ment Defic Res; 1967 Dec; 11(4):246-53. PubMed ID: 5582926
[No Abstract] [Full Text] [Related]
9. Urinary excretion of succinylacetone and delta-aminolevulinic acid in patients with hereditary tyrosinemia.
Christensen E; Jacobsen BB; Gregersen N; Hjeds H; Pedersen JB; Brandt NJ; Baekmark UB
Clin Chim Acta; 1981 Nov; 116(3):331-41. PubMed ID: 7296896
[TBL] [Abstract][Full Text] [Related]
10. Tyrosinaemia and tyrosyluria in infancy.
Wong PW; Lambert AM; Komrower GM
Dev Med Child Neurol; 1967 Oct; 9(5):551-62. PubMed ID: 6066020
[No Abstract] [Full Text] [Related]
11. Plasma antioxidant capacity in two cases of tyrosinaemia type 1: one case treated with NTBC.
Bird S; Miller NJ; Collins JE; Rice-Evans CA
J Inherit Metab Dis; 1995; 18(2):123-6. PubMed ID: 7564225
[No Abstract] [Full Text] [Related]
12. Biochemical studies in a patient with "tyrosinosis".
Louis WJ; Pitt DD; Davies H
Aust N Z J Med; 1974 Jun; 4(3):281-6. PubMed ID: 4531904
[No Abstract] [Full Text] [Related]
13. Urinary succinylacetone presence and delta-aminolaevulinic acid excretion in patients with type I tyrosinaemia during treatment.
Pronicka E; Mielniczuk Z; Rowińska E; Ksiazyk J; Szczygielska-Kozak M; Wieczorek E; Kulczycka H
Mater Med Pol; 1991; 23(2):136-8. PubMed ID: 1842600
[TBL] [Abstract][Full Text] [Related]
14. Neonatal and prenatal diagnosis of hereditary tyrosinaemia.
King GS; MacKenzie F; Pettit BR
Lancet; 1983 Jun; 1(8336):1279. PubMed ID: 6134070
[No Abstract] [Full Text] [Related]
15. Dietary treatment of tyrosinemia type I: importance of methionine restriction.
Michals K; Matolon R; Wong PW
J Am Diet Assoc; 1978 Nov; 73(5):507-14. PubMed ID: 701680
[TBL] [Abstract][Full Text] [Related]
16. Neonatal screen for hereditary tyrosinaemia type I.
Holme E; Lindstedt S
Lancet; 1992 Oct; 340(8823):850. PubMed ID: 1357267
[No Abstract] [Full Text] [Related]
17. Proceedings: Biochemical studies on a patient with features suggestive of hereditary tyrosinaemia.
Chalmers RA; Liberman M; Watts RW
Clin Sci Mol Med; 1974 Feb; 46(2):14P. PubMed ID: 4817255
[No Abstract] [Full Text] [Related]
18. Impaired synthesis of taurine in a patient with tyrosinemia type I during the oral L-methionine loading test.
Valík D; Klusácek D; Pintera J
Clin Chim Acta; 1992 Sep; 210(3):227-9. PubMed ID: 1468144
[No Abstract] [Full Text] [Related]
19. Richner-Hanhart syndrome (oculocutaneous tyrosinaemia, tyrosinaemia type II).
Paige DG; Clayton P; Bowron A; Harper JI
J R Soc Med; 1992 Dec; 85(12):759-60. PubMed ID: 1362969
[No Abstract] [Full Text] [Related]
20. Tyrosinaemia type I and hypertrophic obstructive cardiomyopathy.
Edwards MA; Green A; Colli A; Rylance G
Lancet; 1987 Jun; 1(8547):1437-8. PubMed ID: 2884531
[No Abstract] [Full Text] [Related]
[Next] [New Search]
